Early-onset sutural cataract
diseaseOn this page
Also known as early-onset cataract with Y-shaped suture opacities
Summary
Early-onset sutural cataract (MONDO:0020372) is a disease with 7 cohort genes.
At a glance
- Cohort genes: 7
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | early-onset sutural cataract |
| Mondo ID | MONDO:0020372 |
| Orphanet | 98985 |
| GARD | 0016885 |
| Is cancer (heuristic) | no |
Also known as: early-onset cataract with Y-shaped suture opacities
Data availability: 6 GenCC gene-disease records.
Disease family
An umbrella term covering 1 Mondo subtype.
Classification path: disease › human disease › disease by body system or component › disorder of orbital region › eye disorder › lens disorder › cataract › early-onset non-syndromic cataract › early-onset partial cataract › early-onset zonular cataract › early-onset sutural cataract
Related subtypes (2): cataract 16 multiple types, early-onset nuclear cataract
Subtypes (1): cataract 25
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
Mendelian disease overlap and somatic drivers
GenCC: 62 · Orphanet: 28 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0
GenCC gene–disease validity (cohort genes)
the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.
| Gene | Classification | Inheritance | Disease | Records |
|---|---|---|---|---|
| BFSP2 | Definitive | Autosomal dominant | cataract 12 multiple types | 9 |
| CRYBA1 | Definitive | Autosomal dominant | cataract 10 multiple types | 7 |
| CRYBB2 | Definitive | Autosomal dominant | cataract 3 multiple types | 11 |
| CRYGS | Definitive | Autosomal dominant | cataract 20 multiple types | 5 |
| GJA8 | Definitive | Autosomal dominant | cataract 1 multiple types | 9 |
| MIP | Definitive | Autosomal dominant | cataract 15 multiple types | 10 |
| TNPO1 | Definitive | Autosomal dominant | cataract 15 multiple types | 11 |
Orphanet rare-disease linkage (cohort genes)
| Gene | Orphanet ID | Rare disease |
|---|---|---|
| BFSP2 | Orphanet:441452 | Early-onset lamellar cataract |
| BFSP2 | Orphanet:98984 | Pulverulent cataract |
| BFSP2 | Orphanet:98985 | Early-onset sutural cataract |
| CRYBA1 | Orphanet:441452 | Early-onset lamellar cataract |
| CRYBA1 | Orphanet:98985 | Early-onset sutural cataract |
| CRYBA1 | Orphanet:98991 | Early-onset nuclear cataract |
| CRYBA1 | Orphanet:98993 | Early-onset posterior polar cataract |
| CRYBB2 | Orphanet:1377 | Cataract-microcornea syndrome |
| CRYBB2 | Orphanet:441447 | Early-onset posterior subcapsular cataract |
| CRYBB2 | Orphanet:98984 | Pulverulent cataract |
| CRYBB2 | Orphanet:98985 | Early-onset sutural cataract |
| CRYBB2 | Orphanet:98989 | Cerulean cataract |
| CRYBB2 | Orphanet:98991 | Early-onset nuclear cataract |
| CRYBB2 | Orphanet:98994 | Total early-onset cataract |
| CRYGS | Orphanet:441452 | Early-onset lamellar cataract |
| CRYGS | Orphanet:98985 | Early-onset sutural cataract |
| GJA8 | Orphanet:1377 | Cataract-microcornea syndrome |
| GJA8 | Orphanet:91490 | Isolated congenital sclerocornea |
| GJA8 | Orphanet:98984 | Pulverulent cataract |
| GJA8 | Orphanet:98985 | Early-onset sutural cataract |
| GJA8 | Orphanet:98991 | Early-onset nuclear cataract |
| GJA8 | Orphanet:98994 | Total early-onset cataract |
| MIP | Orphanet:441452 | Early-onset lamellar cataract |
| MIP | Orphanet:98985 | Early-onset sutural cataract |
| MIP | Orphanet:98989 | Cerulean cataract |
| MIP | Orphanet:98991 | Early-onset nuclear cataract |
| MIP | Orphanet:98993 | Early-onset posterior polar cataract |
| MIP | Orphanet:98994 | Total early-onset cataract |
Cohort genes → proteins
7 cohort genes, 7 distinct canonical proteins.
Evidence partition
| Subset | Genes |
|---|---|
| multi_evidence | 7 |
Cohort genes (full)
| Symbol | HGNC | Ensembl | UniProt | Name | Evidence |
|---|---|---|---|---|---|
| BFSP2 | HGNC:1041 | ENSG00000170819 | Q13515 | Phakinin | gencc |
| CRYBA1 | HGNC:2394 | ENSG00000108255 | P05813 | Beta-crystallin A3 | gencc |
| CRYBB2 | HGNC:2398 | ENSG00000244752 | P43320 | Beta-crystallin B2 | gencc |
| CRYGS | HGNC:2417 | ENSG00000213139 | P22914 | Gamma-crystallin S | gencc |
| GJA8 | HGNC:4281 | ENSG00000121634 | P48165 | Gap junction alpha-8 protein | gencc |
| TNPO1 | HGNC:6401 | ENSG00000083312 | Q92973 | Transportin-1 | gencc |
| MIP | HGNC:7103 | ENSG00000135517 | P30301 | Lens fiber major intrinsic protein | gencc |
Cohort function summary
Lead sentence per gene, UniProt-curated.
| Symbol | Protein name | Function (lead sentence) |
|---|---|---|
| BFSP2 | Phakinin | Required for the correct formation of lens intermediate filaments as part of a complex composed of BFSP1, BFSP2 and CRYAA. |
| CRYBA1 | Beta-crystallin A3 | Crystallins are the dominant structural components of the vertebrate eye lens. |
| CRYBB2 | Beta-crystallin B2 | Crystallins are the dominant structural components of the vertebrate eye lens. |
| CRYGS | Gamma-crystallin S | Crystallins are the dominant structural components of the vertebrate eye lens. |
| GJA8 | Gap junction alpha-8 protein | Structural component of eye lens gap junctions. |
| TNPO1 | Transportin-1 | Functions in nuclear protein import as nuclear transport receptor. |
| MIP | Lens fiber major intrinsic protein | Aquaporins form homotetrameric transmembrane channels, with each monomer independently mediating water transport across the plasma membrane along its osmotic gradient. |
Protein-family classification
Druggable: 0 · Difficult: 0 · Unknown: 7 · Druggable fraction: 0.0
Family distribution
Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.
| Family | Genes | Fold | FDR |
|---|---|---|---|
| Other/Unknown | 7 | 1.8× | 0.017 |
Per-gene assignment
| Symbol | Family | Druggable? | EC | InterPro (top 3) |
|---|---|---|---|---|
| BFSP2 | Other/Unknown | no | Keratin_I, IF_rod_dom | |
| CRYBA1 | Other/Unknown | no | Beta/gamma_crystallin, G_crystallin-like, Beta/Gamma-Crystallin | |
| CRYBB2 | Other/Unknown | no | Beta/gamma_crystallin, G_crystallin-like, Beta/Gamma-Crystallin | |
| CRYGS | Other/Unknown | no | Beta/gamma_crystallin, G_crystallin-like, Beta/Gamma-Crystallin | |
| GJA8 | Other/Unknown | no | Connexin, Connexin50_C, Connexin_N | |
| TNPO1 | Other/Unknown | no | Importin-beta_N, ARM-like, ARM-type_fold | |
| MIP | Other/Unknown | no | MIP, MIP_CS, Aquaporin-like |
Expression context
Cohort genes with no expression data: 0.
1 cohort gene are a single-cell marker in ≥1 SCXA experiment.
Breadth distribution (Bgee present_calls)
| Bucket | Genes |
|---|---|
| narrow (1-5 tissues) | 0 |
| moderate (6-20) | 1 |
| broad (>20) | 6 |
| unknown | 0 |
Top tissues across cohort
| Tissue | Cohort genes |
|---|---|
| lens of camera-type eye | 3 |
| male germ line stem cell (sensu Vertebrata) in testis | 3 |
| primordial germ cell in gonad | 3 |
| gluteal muscle | 1 |
| trabecular bone tissue | 1 |
| triceps brachii | 1 |
| cerebellar cortex | 1 |
| cerebellar hemisphere | 1 |
| buccal mucosa cell | 1 |
| frontal pole | 1 |
| paraflocculus | 1 |
| caput epididymis | 1 |
| cauda epididymis | 1 |
| corpus epididymis | 1 |
| right lobe of liver | 1 |
Per-gene tissue summary (top 30)
| Symbol | Bgee breadth | FANTOM5 breadth | SCXA | Top tissues |
|---|---|---|---|---|
| BFSP2 | 111 | tissue_specific | yes | lens of camera-type eye, male germ line stem cell (sensu Vertebrata) in testis, primordial germ cell in gonad |
| CRYBA1 | 138 | tissue_specific | yes | lens of camera-type eye, primordial germ cell in gonad, male germ line stem cell (sensu Vertebrata) in testis |
| CRYBB2 | 144 | tissue_specific | yes | triceps brachii, gluteal muscle, trabecular bone tissue |
| CRYGS | 179 | tissue_specific | yes | lens of camera-type eye, cerebellar hemisphere, cerebellar cortex |
| GJA8 | 17 | tissue_specific | yes | buccal mucosa cell, frontal pole, paraflocculus |
| TNPO1 | 295 | ubiquitous | marker | corpus epididymis, caput epididymis, cauda epididymis |
| MIP | 91 | tissue_specific | yes | male germ line stem cell (sensu Vertebrata) in testis, primordial germ cell in gonad, right lobe of liver |
Protein interactions among cohort
Intra-cohort edges: 11.
Hub genes (top 10 by interactor count)
| Symbol | Interactor count |
|---|---|
| TNPO1 | 3,147 |
| MIP | 2,496 |
| BFSP2 | 1,203 |
| GJA8 | 1,149 |
| CRYBA1 | 925 |
| CRYBB2 | 548 |
| CRYGS | 513 |
Intra-cohort edges
| A | B | Sources |
|---|---|---|
| BFSP2 | CRYBA1 | string_interaction |
| BFSP2 | CRYBB2 | string_interaction |
| BFSP2 | CRYGS | string_interaction |
| BFSP2 | GJA8 | string_interaction |
| BFSP2 | MIP | string_interaction |
| CRYBA1 | CRYBB2 | biogrid_interaction, intact |
| CRYBA1 | GJA8 | string_interaction |
| CRYBB2 | GJA8 | string_interaction |
| CRYGS | GJA8 | string_interaction |
| CRYGS | MIP | string_interaction |
| GJA8 | MIP | string_interaction |
Structural data
PDB: 3 · AlphaFold-only: 4 · No structure: 0
Cohort genes with PDB structures (top 30)
| Symbol | UniProt | PDB entries |
|---|---|---|
| TNPO1 | Q92973 | 21 |
| CRYGS | P22914 | 12 |
| CRYBB2 | P43320 | 3 |
AlphaFold-only cohort genes (top 30 by pLDDT)
| Symbol | UniProt | pLDDT |
|---|---|---|
| MIP | P30301 | 91.08 |
| CRYBA1 | P05813 | 88.27 |
| BFSP2 | Q13515 | 78.15 |
| GJA8 | P48165 | 65.85 |
Function
Pathway analysis
Distinct Reactome pathways touched by cohort: 7. Enrichment computed across 7 evidence-associated genes (3 with Reactome annotation).
Pathways by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 3 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| Pathway | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| Passive transport by Aquaporins | 1 | 292.8× | 0.014 | MIP |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | 1 | 211.5× | 0.014 | TNPO1 |
| Postmitotic nuclear pore complex (NPC) reformation | 1 | 135.9× | 0.014 | TNPO1 |
| Aquaporin-mediated transport | 1 | 122.8× | 0.014 | MIP |
| Gap junction assembly | 1 | 97.6× | 0.014 | GJA8 |
| Intraflagellar transport | 1 | 66.8× | 0.017 | TNPO1 |
| Transport of small molecules | 1 | 8.4× | 0.115 | MIP |
GO biological processes by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 7 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| GO term | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| lens development in camera-type eye | 5 | 267.5× | 4e-11 | CRYBA1, CRYBB2, CRYGS, GJA8, MIP |
| visual perception | 5 | 56.8× | 6e-08 | BFSP2, CRYBA1, CRYBB2, CRYGS, MIP |
| gap junction-mediated intercellular transport | 2 | 802.5× | 1e-05 | GJA8, MIP |
| maintenance of lens transparency | 1 | 300.9× | 0.011 | MIP |
| lens fiber cell development | 1 | 300.9× | 0.011 | BFSP2 |
| positive regulation of anoikis | 1 | 267.5× | 0.011 | CRYBA1 |
| homotypic cell-cell adhesion | 1 | 240.7× | 0.011 | MIP |
| water transport | 1 | 141.6× | 0.017 | MIP |
| negative regulation of TOR signaling | 1 | 80.2× | 0.026 | CRYBA1 |
| negative regulation of cytokine production | 1 | 73.0× | 0.026 | CRYBA1 |
| cell maturation | 1 | 63.4× | 0.027 | BFSP2 |
| morphogenesis of an epithelium | 1 | 49.1× | 0.032 | CRYGS |
| negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 1 | 37.6× | 0.034 | CRYBA1 |
| phagocytosis | 1 | 34.4× | 0.034 | CRYBA1 |
| regulation of autophagy | 1 | 34.4× | 0.034 | CRYBA1 |
| intermediate filament organization | 1 | 34.4× | 0.034 | BFSP2 |
| negative regulation of ERK1 and ERK2 cascade | 1 | 30.9× | 0.036 | CRYBA1 |
| protein import into nucleus | 1 | 20.6× | 0.050 | TNPO1 |
| cell-cell signaling | 1 | 9.9× | 0.096 | GJA8 |
Therapeutics
Drug target analysis
Approved (phase 4): 0 · Phase ≥3: 0 · Phased (≥1): 0 · Undrugged: 7
Druggability breadth: 2 of 7 evidence-associated genes (29%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).
Top cohort targets by molecule count
| Symbol | Molecules | Max phase |
|---|---|---|
| BFSP2 | 0 | 0 |
| CRYBA1 | 0 | 0 |
| CRYBB2 | 0 | 0 |
| CRYGS | 0 | 0 |
| GJA8 | 0 | 0 |
| TNPO1 | 0 | 0 |
| MIP | 0 | 0 |
Bioactivity and enzyme data
Enzyme cohort genes (≥1 EC): 0.
Cohort genes with ChEMBL bioactivity (full, sorted by assay count)
| Symbol | Assays | Type breakdown |
|---|---|---|
| CRYBB2 | 9 | Binding:9 |
| TNPO1 | 7 | Binding:7 |
Pharmacogenomics
Cohort genes with a PharmGKB record: 7; with CPIC/DPWG dosing guidelines: 0.
No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).
Chemical tractability of cohort targets
0 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.
Druggability pyramid
Cohort genes binned by druggability tier (high → low):
| Tier | Definition | Genes | Symbols |
|---|---|---|---|
| A | Approved (phase 4 drug) | 0 | |
| B | Phased (≥1) drug, not yet approved | 0 | |
| C | Druggable family + PDB, no drug | 0 | |
| D | Druggable family + AlphaFold only, no drug | 0 | |
| E | Difficult family or no structure, no drug | 7 | BFSP2, CRYBA1, CRYBB2, CRYGS, GJA8, TNPO1, MIP |
Undrugged target profiles
7 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).
| Symbol | ChEMBL assays | Drugged partners (top 3) |
|---|---|---|
| BFSP2 | 0 | — |
| CRYBA1 | 0 | — |
| CRYBB2 | 9 | — |
| CRYGS | 0 | — |
| GJA8 | 0 | — |
| TNPO1 | 7 | — |
| MIP | 0 | — |
Clinical trials & evidence
Clinical trials
Clinical trials: 0.